发明名称 |
Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
摘要 |
Cysteine engineered anti-TENB2 antibodies are engineered by replacing one or more amino acids of a parent anti-TENB2 antibody with non cross-linked, reactive cysteine amino acids. Methods of design, preparation, screening, and selection of the cysteine engineered anti-TENB2 antibodies are provided. Cysteine engineered anti-TENB2 antibodies (Ab) are conjugated with one or more drug moieties (D) through a linker (L) to form cysteine engineered anti-TENB2 antibody-drug conjugates having Formula I:
Ab-(L-D)p Iwhere p is 1 to 4. Diagnostic and therapeutic uses for cysteine engineered antibody drug compounds and compositions are disclosed. |
申请公布号 |
US8937161(B2) |
申请公布日期 |
2015.01.20 |
申请号 |
US200812288181 |
申请日期 |
2008.10.16 |
申请人 |
Genentech, Inc. |
发明人 |
Mao Weiguang;Junutula Jagath Reddy;Polakis Paul |
分类号 |
C12P21/08;A61K47/48 |
主分类号 |
C12P21/08 |
代理机构 |
Arnold & Porter LLP |
代理人 |
Martineau Janet;Soneoka Yuko;Arnold & Porter LLP |
主权项 |
1. A cysteine engineered anti-TENB2 antibody comprising a heavy and a light chain, one or more free cysteine amino acid residues located in the heavy chain, and the sequence:Sequence near SequentialKabat Seq. Cys mutationNumberingNumberingI.D.VTVSSCSTKGPA121CA114C12 in combination with one or more additional cysteine mutations in the heavy chain, selected from the group consisting of:Sequence near SequentialKabat Seq. Cys mutationNumberingNumberingI.D.DVQLCESGPGQ5CQ5C 8LSLTCCVSGYSA23CA23C 9VSSASCKGPSVT123CT116C13WYVDGCEVHNAV285CV278C14 KGFYPCDIAVES378CS371C15 PPVLDCDGSFFS403CS396C 16. |
地址 |
South San Francisco CA US |